Catalyst Wire Dossier Catalyst Wire Dossier

ZONISADE

· Azurity Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZONISADE, covering 2022-07-15 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures [Phase 4]

See pricing